IGMS
Legal & General Group’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,746
| Closed | -$2.02K | – | 3471 |
|
|
2025
Q1 | $2.02K | Hold |
1,746
| – | – | ﹤0.01% | 3353 |
|
|
2024
Q4 | $10.7K | Hold |
1,746
| – | – | ﹤0.01% | 3241 |
|
|
2024
Q3 | $28.9K | Buy |
1,746
+385
| +28% | +$6.37K | ﹤0.01% | 2909 |
|
|
2024
Q2 | $9.35K | Buy |
1,361
+338
| +33% | +$2.32K | ﹤0.01% | 3314 |
|
|
2024
Q1 | $9.82K | Sell |
1,023
-565
| -36% | -$5.42K | ﹤0.01% | 3205 |
|
|
2023
Q4 | $13.2K | Sell |
1,588
-12,635
| -89% | -$105K | ﹤0.01% | 3178 |
|
|
2023
Q3 | $119K | Buy |
14,223
+2,732
| +24% | +$22.8K | ﹤0.01% | 2810 |
|
|
2023
Q2 | $106K | Buy |
11,491
+7,253
| +171% | +$66.9K | ﹤0.01% | 2828 |
|
|
2023
Q1 | $58.2K | Buy |
4,238
+190
| +5% | +$2.61K | ﹤0.01% | 2851 |
|
|
2022
Q4 | $68.9K | Buy |
4,048
+399
| +11% | +$6.79K | ﹤0.01% | 2891 |
|
|
2022
Q3 | $83K | Buy |
3,649
+435
| +14% | +$9.89K | ﹤0.01% | 2866 |
|
|
2022
Q2 | $58K | Buy |
3,214
+367
| +13% | +$6.62K | ﹤0.01% | 2979 |
|
|
2022
Q1 | $76K | Hold |
2,847
| – | – | ﹤0.01% | 2927 |
|
|
2021
Q4 | $84K | Hold |
2,847
| – | – | ﹤0.01% | 2945 |
|
|
2021
Q3 | $186K | Buy |
2,847
+1,511
| +113% | +$98.7K | ﹤0.01% | 2715 |
|
|
2021
Q2 | $112K | Buy |
1,336
+188
| +16% | +$15.8K | ﹤0.01% | 2695 |
|
|
2021
Q1 | $88K | Buy |
1,148
+12
| +1% | +$920 | ﹤0.01% | 2651 |
|
|
2020
Q4 | $100K | Sell |
1,136
-40
| -3% | -$3.52K | ﹤0.01% | 2588 |
|
|
2020
Q3 | $87K | Sell |
1,176
-306
| -21% | -$22.6K | ﹤0.01% | 2527 |
|
|
2020
Q2 | $109K | Buy |
1,482
+681
| +85% | +$50.1K | ﹤0.01% | 2502 |
|
|
2020
Q1 | $43K | Sell |
801
-182
| -19% | -$9.77K | ﹤0.01% | 2643 |
|
|
2019
Q4 | $37K | Buy |
+983
| New | +$37K | ﹤0.01% | 2942 |
|